ADOLOR CORPORATION

Basic Information

371 PHOENIXVILLE PIKE
MALVERN, PA, 19355

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Novel Cannabinoid Receptor Agonists as Analgesics

    Amount: $157,110.00

    DESCRIPTION (provided by applicant): Pain is a serious, debilitating condition that is undertreated because because of the dose-limiting side effects of currently used therapeutics. A ...

    SBIR Phase I 2001 Department of Health and Human Services
  2. Discovery of K Opioid Analgesics Using Chimeric Receptor

    Amount: $106,026.00

    DESCRIPTION (provided by applicant): Pain is a serious, debilitating condition that is under treated because of the dose limiting side effects of currently used opiate therapeutics inclu ...

    SBIR Phase I 2001 Department of Health and Human Services
  3. Novel Antagonists of the ORL-1 Receptor

    Amount: $0.00

    N/A

    SBIR Phase I 2001 Department of Health and Human Services
  4. Novel Antagonists of the ORL-1 Receptor

    Amount: $822,158.00

    N/A

    SBIR Phase II 2001 Department of Health and Human Services
  5. IDENTIFICATION OF NOVEL LIGANDS FOR THE ORL-1 RECEPTOR

    Amount: $99,983.00

    N/A

    SBIR Phase I 1997 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government